Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 44

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 44
---
 policy (the “Amended Director Compensation Policy”). Prior to the Board’s adoption of the Amended Director Compensation Policy, each non-employeedirector received an annual retainer of $35,000. The chair of our Board received an additional annual retainer of $30,000. Non-employeedirectors serving as the chairs of the Audit, Compensation, Nominating and Corporate Governance, and Science and Technology Committees received additional annual retainers of $15,000, $10,000, $8,000, and $10,000, respectively. The non-employeedirectors serving as members of the Audit, Compensation, Nominating and Corporate Governance, and Science and Technology Committees received additional annual retainers of $7,500, $5,000, $4,000, and $5,000, respectively. The non-employeedirectors also received initial grants of options to purchase 29,000 shares of our Common Stock, vesting over three years, upon election to the Board, and thereafter annual grants of options to purchase 14,500 shares of our Common Stock, vesting in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the next annual meeting of our stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the annual award will vest on the date of such annual meeting of our stockholders). Awards to our non-employeedirectors also vest in the event of a change in control. Following the Board’s adoption of the Amended Director Compensation Policy, each non-employeedirector receives the same annual retainer fees and/or long-term equity awards as set forth in the preceding paragraph, except that: (1) the annual retainer that each non-employeedirector receives has been increased from $35,000 to $40,000; (2) the initial grant of options that non-employeedirectors receive upon their election to the Board has 28

been increased from 29,000 options to 37,200 options; and (3) the annual grant of options that non-employeedirectors receive has been increased from 14,500 options to 18,600 options. Compensation under our non-employeedirector compensation policy is subject to the annual limits on non-employeedirector compensation set forth in the 2021 Plan. Our Board or its authorized committee may modify the non-employeedirector compensation program from time to